Grantham, Mayo, Van Otterloo & Co (GMO)
SYK icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Stryker SYK Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,892
Closed -$704K – 683
2025
Q1 		$704K Buy
+1,892
New +$720K ﹤0.01% 495
2020
Q1 		– Sell
-1,300
Closed -$273K – 818
2019
Q4 		$273K Sell
1,300
-45,859
-97% -$9.52M ﹤0.01% 636
2019
Q3 		$10.2M Sell
47,159
-30,539
-39% -$6.55M 0.07% 182
2019
Q2 		$16M Buy
+77,698
New +$14.8M 0.11% 138
2018
Q4 		– Sell
-316,641
Closed -$56.3M – 582
2018
Q3 		$56.3M Sell
316,641
-203,114
-39% -$34.7M 0.38% 59
2018
Q2 		$87.8M Sell
519,755
-367,622
-41% -$61.8M 0.62% 44
2018
Q1 		$143M Sell
887,377
-123,985
-12% -$20M 0.87% 36
2017
Q4 		$157M Sell
1,011,362
-64,308
-6% -$9.81M 0.92% 34
2017
Q3 		$153M Sell
1,075,670
-92,051
-8% -$13.2M 0.89% 33
2017
Q2 		$162M Buy
1,167,721
+16,753
+1% +$2.3M 0.89% 30
2017
Q1 		$152M Sell
1,150,968
-319,814
-22% -$40.4M 0.85% 31
2016
Q4 		$176M Buy
1,470,782
+85,014
+6% +$9.78M 0.95% 26
2016
Q3 		$161M Buy
1,385,768
+64,500
+5% +$7.52M 0.76% 27
2016
Q2 		$158M Buy
1,321,268
+34,173
+3% +$3.82M 0.65% 36
2016
Q1 		$138M Sell
1,287,095
-180,274
-12% -$17.8M 0.52% 48
2015
Q4 		$136M Sell
1,467,369
-223,507
-13% -$21.4M 0.49% 51
2015
Q3 		$159M Sell
1,690,876
-437,080
-21% -$43.3M 0.55% 41
2015
Q2 		$203M Sell
2,127,956
-250,500
-11% -$23.7M 0.66% 35
2015
Q1 		$219M Buy
2,378,456
+115,775
+5% +$10.8M 0.65% 39
2014
Q4 		$213M Buy
2,262,681
+127,134
+6% +$11.3M 0.57% 41
2014
Q3 		$172M Buy
2,135,547
+88,345
+4% +$7.27M 0.46% 46
2014
Q2 		$173M Sell
2,047,202
-425,500
-17% -$34.7M 0.47% 43
2014
Q1 		$201M Sell
2,472,702
-164,020
-6% -$13M 0.53% 40
2013
Q4 		$198M Buy
2,636,722
+340,720
+15% +$24.9M 0.48% 44
2013
Q3 		$155M Buy
2,296,002
+681,638
+42% +$47.1M 0.41% 49
2013
Q2 		$104M Buy
+1,614,364
New +$107M 0.27% 56

Other funds holding SYK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SYK Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Stryker (SYK) in Q2 2025, closing a stake of 1,892 shares — an estimated $704K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SYK in Q2 2013 and held it in 26 quarters. The position peaked at $219M in Q1 2015. 2,256 funds tracked by Wall St. Rank hold SYK as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Stryker position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,892 Stryker shares in Q2 2025, an estimated $704K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Stryker in Q2 2013 and held it in 26 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Stryker position peaked at $219M in Q1 2015.
  • 2,256 funds tracked by Wall St. Rank held Stryker as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.